Tolterodine
Tolterodine is an antimuscarinic medicine used to treat overactive bladder — including the urge to urinate frequently, sudden strong urges, and urge-related leakage.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 25 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Tolterodine: Patient Information Guide
A plain-language walkthrough of Tolterodine — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Tolterodine is approved across all its available forms to treat overactive bladder.
- Urge urinary incontinence — leaking urine when a sudden urge strikes
- Urgency — a sudden, strong need to urinate that is hard to delay
- Urinary frequency — urinating more often than normal
Detrol and Tolterodine Tartrate tablets, as well as Detrol LA and Tolterodine Tartrate extended-release capsules, are all approved for this same set of symptoms. No other uses are listed in the prescribing information for any of these products.
⚙️How it works▾
Tolterodine works by blocking muscarinic receptors — the docking sites that the chemical messenger acetylcholine uses to trigger bladder contractions. By blocking these receptors, tolterodine reduces the overactive squeezing of the bladder that causes urgency, frequency, and leakage. The liver converts tolterodine into an active metabolite (called 5-HMT) that carries much of the therapeutic effect. Both the original drug and 5-HMT are highly selective for muscarinic receptors and have little activity at other receptor types.
About 7% of Caucasians and about 2% of African Americans process tolterodine more slowly (called poor metabolizers) because of a genetic difference in the CYP2D6 enzyme. In these individuals, tolterodine levels run higher and 5-HMT levels are lower — which can influence both effectiveness and side effect risk. Prescribers may account for this when selecting a dose.
💊How it's taken▾
Tolterodine comes as immediate-release tablets taken twice daily and as extended-release capsules taken once daily. Extended-release capsules should be swallowed whole with water — never crushed or chewed. Food does not affect the absorption of the extended-release capsule, so it can be taken at any time. Tablets may be taken with or without food as well, though food does increase absorption somewhat — this is not considered a safety concern and no dose change is needed.
- Always follow your prescriber's exact directions; doses may be adjusted based on how well your kidneys and liver are working or other medications you take
- If you miss a dose, follow the guidance on your label or ask your pharmacist — do not double up
🤒Side effects — in detail▾
The most common side effects of tolterodine are typical of medicines that work by blocking muscarinic receptors:
- Dry mouth (most frequently reported — affects about 1 in 3 people taking the tablet form)
- Constipation
- Headache
- Dizziness or vertigo
- Abdominal pain
- Blurred vision or trouble focusing (accommodation abnormalities)
- Dry eyes (xerophthalmia)
- Drowsiness
- Indigestion (dyspepsia)
Serious reactions — including severe allergic reactions (anaphylaxis, angioedema with throat swelling), inability to urinate, confusion, hallucinations, or a fast/irregular heartbeat — require immediate medical attention. These are less common but have been reported in post-marketing use.
⚠️Warnings & precautions▾
- Severe allergic reactions: Anaphylaxis and angioedema (life-threatening airway swelling) have occurred — even after the first dose. Stop tolterodine and seek emergency care if you have trouble breathing, throat tightening, or a sudden blood pressure drop.
- Urinary retention: Tolterodine can make it harder to empty your bladder. Use with extra caution if you already have a bladder outflow obstruction.
- Stomach and bowel slowing: Like all antimuscarinics, tolterodine slows gut movement. It should be used carefully in people with GI blockages or conditions like intestinal atony (a poorly moving bowel).
- Drowsiness and brain effects: Tolterodine can cause dizziness, drowsiness, confusion, and disorientation — especially early in treatment or after a dose increase. Avoid driving or operating machinery until you know how it affects you.
- Heart rhythm (QT prolongation): At higher-than-recommended exposures, tolterodine can lengthen the QT interval (a measure of heart electrical activity). People with a known history of QT prolongation or those on certain heart-rhythm drugs need special consideration.
- Narrow-angle glaucoma: Tolterodine is contraindicated in uncontrolled narrow-angle glaucoma and should be used with caution even in treated cases.
- Liver and kidney disease: Both conditions slow how tolterodine is cleared — lower doses are required for moderate liver or severe kidney impairment, and the extended-release capsule is not recommended at all in severe liver disease or very low kidney function.
🔀What it interacts with▾
Several medications can change how tolterodine works in your body, or make its side effects worse:
- Strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin, ritonavir) — these raise tolterodine blood levels significantly; a lower dose of the extended-release capsule is recommended when any of these are used together
- Fluoxetine (CYP2D6 inhibitor) — changes how tolterodine is broken down, but the overall active drug level rises only modestly; no dose change needed, but your doctor should know
- Other anticholinergic (antimuscarinic) drugs — combining them with tolterodine stacks up the anticholinergic effects, worsening dry mouth, constipation, blurred vision, and drowsiness
- Warfarin, oral contraceptives, and diuretics — no clinically meaningful interaction was found in studies; these can generally be used together without special precautions related to tolterodine
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not take if you have urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma — these are absolute contraindications
- Do not take if you are allergic to tolterodine, any of its ingredients, or to fesoterodine fumarate extended-release tablets (it converts to the same active form in the body)
- Liver disease: If you have mild to moderate liver impairment, a lower dose is used; the extended-release capsule should not be used in severe liver disease
- Kidney disease: If you have severe kidney impairment, a lower dose is needed; the extended-release capsule is not recommended when kidney function is very low
- Bladder or bowel obstruction: Tell your doctor if you have any blockage in your urinary or digestive tract, or a condition that slows gut movement
- Narrow-angle glaucoma being treated: Use with caution and only under close medical supervision
- Myasthenia gravis (a nerve-muscle disorder causing weakness): use with caution
- Heart rhythm problems: Tell your doctor if you have a history of prolonged QT interval or take antiarrhythmic medications such as quinidine, procainamide, amiodarone, or sotalol
- Older adults and those with dementia: Post-marketing reports describe worsening confusion and disorientation, especially in patients taking cholinesterase inhibitors for dementia — discuss risks carefully with your doctor
🚑If you take too much▾
Taking too much tolterodine can cause severe anticholinergic effects — things like extreme dry mouth, inability to urinate, confusion, fast heart rate, and blurred vision. Heart rhythm monitoring (an ECG) is recommended if an overdose occurs. In a reported case, a young child who accidentally swallowed several tablets was treated with activated charcoal, observed overnight, and fully recovered.
📡Pharmacodynamics — effects in the body▾
Tolterodine's most measurable effect is on the bladder: it increases the amount of urine left after urinating (residual urine) and reduces the pressure the bladder muscle generates during filling. These effects reflect its antimuscarinic action on the lower urinary tract — calming an overactive bladder rather than fully suppressing normal bladder function. At doses higher than the recommended therapeutic range, tolterodine can also lengthen the QT interval on an ECG (a measure of heart electrical recovery time), and this effect correlates with how much tolterodine is in the bloodstream.
🔬Pharmacokinetics — how your body processes it▾
Tolterodine is well absorbed after oral dosing and is extensively processed by the liver into its main active form, 5-HMT. The extended-release capsule releases the drug slowly, reaching peak blood levels 2 to 6 hours after a dose, while the tablet form peaks within 1 to 2 hours. About 7% of Caucasians and 2% of African Americans carry a genetic variation that causes them to process tolterodine more slowly (via the CYP2D6 enzyme), leading to higher tolterodine levels and lower 5-HMT levels. Most of the drug and its breakdown products are eliminated in the urine over about 7 days.
📦How to store it▾
Tolterodine Tartrate Extended-release Capsules, USP are available containing 2 mg or 4 mg of tolterodine tartrate. Store at 25° (77°F); excursions permitted to 15° to 30°C (59 to 86°F) . Protect from light.
📄 Written from Tolterodine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Tolterodine
178 supplements and herbal products have documented interactions with Tolterodine in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 5
- Moderate · 130
- Minor · 43
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Tolterodine — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly does tolterodine do, and how quickly will I notice a difference? ▾
The dry mouth is really bothersome — is there anything I can do about it? ▾
Is it safe to drive while I'm taking this? ▾
I take a few other medications. Are there any I should be worried about? ▾
Are there any serious warning signs I should call my doctor or 911 about? ▾
I have some liver and kidney issues — can I still take tolterodine? ▾
Is Tolterodine available over the counter? ▾
When was Tolterodine first available? ▾
Who makes Tolterodine? ▾
💬 Answers drafted from Tolterodine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Tolterodine comes
Tolterodine is available in 4 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Extended-release capsule
How this form is used
- Detrol LA capsules are indicated for overactive bladder with symptoms of urgency, urge urinary incontinence, and urinary frequency
- Tolterodine Tartrate Extended Release capsules are indicated for overactive bladder with symptoms of urgency, urge urinary incontinence, and urinary frequency
- Detrol LA and Tolterodine Tartrate extended-release capsules are taken once daily by mouth
- Swallow the capsule whole with water — do not crush, chew, or open it
- Food does not affect how the extended-release capsule works, so it can be taken with or without a meal
- Patients with mild to moderate liver disease, severe kidney impairment, or who take strong CYP3A4 inhibitors should take a lower once-daily dose as directed by their prescriber
Tablet
How this form is used
- Detrol tablets are indicated for overactive bladder with symptoms of urgency, urge urinary incontinence, and urinary frequency
- Tolterodine Tartrate tablets are indicated for overactive bladder with symptoms of urgency, urge urinary incontinence, and urinary frequency
- Tablets are taken by mouth twice daily
- Food can increase how much tolterodine your body absorbs from tablets, but no dose adjustment is needed
- Follow your prescriber's directions for the exact schedule that is right for you
Capsule
Extended-release tablet
📊 Tolterodine across the U.S. market
How Tolterodine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (14) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Tolterodine is used
A general measure of how commonly Tolterodine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Tolterodine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Tolterodine prescribed? Of the 1,596 medications we measure, Tolterodine ranks #595 by Medicaid prescriptions — more than 63% of them.
Utilization by Tolterodine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
24 HR tolterodine tartrate 4 MG Extended Release Oral Capsule Most dispensed
Summed across the 19 of 49 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855189
24 HR tolterodine tartrate 2 MG Extended Release Oral Capsule
Summed across the 14 of 44 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855182
tolterodine tartrate 2 MG Oral Tablet
Summed across the 6 of 34 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855194
tolterodine tartrate 1 MG Oral Tablet
Summed across the 5 of 31 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855178
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Tolterodine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 44 of 158 listed Tolterodine NDCs with Medicaid activity.
🔍 Compare Tolterodine products
A representative set of FDA-listed product records for Tolterodine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 2 mg | — | Catalent Pharma Solutions, LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 4 mg | — | Catalent Pharma Solutions, LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 💊Extended-release capsule | ||||
| 2 mg | Oral | A-S Medication Solutions | ANDA | View NDC → |
| 4 mg | Oral | A-S Medication Solutions × 3 listings | ANDA | View NDC → |
| 2 mg | Oral | Ajanta Pharma USA Inc. × 2 listings | ANDA | View NDC → |
| 4 mg | Oral | Ajanta Pharma USA Inc. × 2 listings | ANDA | View NDC → |
| 2 mg | Oral | American Health Packaging × 3 listings | ANDA | View NDC → |
| 4 mg | Oral | American Health Packaging × 3 listings | ANDA | View NDC → |
| 2 mg | Oral | ANI Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 4 mg | Oral | ANI Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 2 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 4 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 2 mg | Oral | Golden State Medical Supply, Inc. × 2 listings | ANDA | View NDC → |
| 4 mg | Oral | Golden State Medical Supply, Inc. × 2 listings | ANDA | View NDC → |
| 2 mg | Oral | Greenstone LLC | NDA | View NDC → |
| 2 mg | Oral | Greenstone LLC | NDA AUTHORIZED GENERIC | View NDC → |
| 4 mg | Oral | Greenstone LLC | NDA | View NDC → |
| 4 mg | Oral | Greenstone LLC | NDA AUTHORIZED GENERIC | View NDC → |
| 2 mg | Oral | Major Pharmaceuticals × 3 listings | ANDA | View NDC → |
| 4 mg | Oral | Major Pharmaceuticals × 4 listings | ANDA | View NDC → |
| 2 mg | Oral | Mylan Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 4 mg | Oral | Mylan Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 2 mg | Oral | Pharmacia and Upjohn Company LLC × 2 listings | NDA | View NDC → |
| 4 mg | Oral | Pharmacia and Upjohn Company LLC × 2 listings | NDA | View NDC → |
| 2 mg | Oral | Slate Run Pharmaceuticals, LLC × 4 listings | ANDA | View NDC → |
| 4 mg | Oral | Slate Run Pharmaceuticals, LLC × 4 listings | ANDA | View NDC → |
| 2 mg | — | Teva Pharmaceuticals USA, Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 2 mg | Oral | Teva Pharmaceuticals USA, Inc. × 3 listings | ANDA | View NDC → |
| 4 mg | Oral | Teva Pharmaceuticals USA, Inc. × 3 listings | ANDA | View NDC → |
| 4 mg | — | Teva Pharmaceuticals USA, Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 2 mg | Oral | Torrent Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 4 mg | Oral | Torrent Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 2 mg | Oral | Unichem Pharmaceuticals (USA), Inc. | ANDA | View NDC → |
| 4 mg | Oral | Unichem Pharmaceuticals (USA), Inc. | ANDA | View NDC → |
| 2 mg | Oral | Viatris Specialty LLC × 2 listings | NDA | View NDC → |
| 4 mg | Oral | Viatris Specialty LLC × 2 listings | NDA | View NDC → |
| 💊Extended-release tablet | ||||
| 1 mg | Oral | Marlex Pharmaceuticals Inc | ANDA | View NDC → |
| 2 mg | Oral | Marlex Pharmaceuticals Inc | ANDA | View NDC → |
| 💊Tablet | ||||
| 1 mg | Oral | Athem LLC × 2 listings | ANDA | View NDC → |
| 2 mg | Oral | Athem LLC × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 2 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 1 mg | Oral | Drug Ocean LLC | ANDA | View NDC → |
| 2 mg | Oral | Drug Ocean LLC | ANDA | View NDC → |
| 1 mg | Oral | Greenstone LLC × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 2 mg | Oral | Greenstone LLC × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 1 mg | Oral | Macleods Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 2 mg | Oral | Macleods Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | Mylan Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 2 mg | Oral | Mylan Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 1 mg | Oral | Pharmacia & Upjohn Company LLC × 2 listings | NDA | View NDC → |
| 2 mg | Oral | Pharmacia & Upjohn Company LLC × 2 listings | NDA | View NDC → |
| 1 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 2 mg | Oral | Remedyrepack Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 2 mg | Oral | Remedyrepack Inc. | ANDA | View NDC → |
| 1 mg | Oral | Rising Pharma Holdings, Inc. × 2 listings | ANDA | View NDC → |
| 2 mg | Oral | Rising Pharma Holdings, Inc. × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 2 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 1 mg | Oral | Unichem Pharmaceuticals (USA), Inc. | ANDA | View NDC → |
| 2 mg | Oral | Unichem Pharmaceuticals (USA), Inc. | ANDA | View NDC → |
| 1 mg | Oral | Viatris Specialty LLC | NDA | View NDC → |
| 2 mg | Oral | Viatris Specialty LLC | NDA | View NDC → |
| 💊Bulk drug substance | ||||
| 50 kg/50 kg | — | Aurobindo Pharma Limited | BULK INGREDIENT | View NDC → |
| 25 kg/25 kg | — | Cipla Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Dr.Reddy's Laboratories Limited | BULK INGREDIENT | View NDC → |
| 50 kg/50 kg | — | Emcure Pharmaceuticals Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Erregierre SpA | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Hetero Drugs Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Holiday Labs Mexico, S.A. De C.V. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Interquim, S.A. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Maithri Laboratories Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | MSN Pharmachem Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Pharmacia & Upjohn Company LLC | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Unichem Laboratories Limited, India | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Viatris Pharmaceuticals LLC × 2 listings | BULK INGREDIENT | View NDC → |
Showing 122 of 122 products — FDA National Drug Code Directory. See every product, package size and price: browse all 122 Tolterodine NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Tolterodine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Tolterodine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Tolterodine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 119565 2 dose forms · 4 strengths
-
Dose form (SCDF) Extended Release Oral Capsule RxCUI 375645In current FDA listingsClinical drug / strength (SCD) 24 HR tolterodine tartrate 2 MGRxCUI 85518224 HR tolterodine tartrate 4 MGRxCUI 855189 -
Dose form (SCDF) Oral Tablet RxCUI 374164In current FDA listings
Look up RxCUI 119565 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Tolterodine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 12 more on the FDA NDC directory.
RxNorm drug class
Tolterodine belongs to the Cholinergic Muscarinic Antagonist class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 25 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. American Health Packaging is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.